EP300 and hepatocellular carcinoma: To validate the PHGDH/cMyc/AF9/P300 axis in clinical samples, we performed endogenous Co‐IP using PHGDH antibody and found that cMyc, AF9, and p300 were associated with PHGDH in advanced HCC (Figure S8, Supporting Information).